CLINICAL IMPACT OF THE 21-GENE RS TEST WITHIN THE VETERANS HEALTH CARE ADMINISTRATION [MEETING ABSTRACT PMD86]

Lynch, J., Chun, DS., Berse, B., Venne, V., Efimova, O., DuVall, S., Filipski, KK., & Kelley, MJ. (2016). CLINICAL IMPACT OF THE 21-GENE RS TEST WITHIN THE VETERANS HEALTH CARE ADMINISTRATION [MEETING ABSTRACT PMD86]. Value in Health, 19(3), A312-A312. https://doi.org/10.1016/j.jval.2016.03.2017

Abstract

Appropriate use of of the 21-gene RS test decreased use of chemotherapy among low risk patients, and produced significant cost savings and potential improvements in health outcomes. Our study demonstrated opportunities to improve access to testing for eligible Veterans.

Download/Explore

Publications Info

To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.

Recent Publications

Article

Treatment preferences among patients with mild-to-moderate atopic dermatitis
Article

Multifaceted risk for non-suicidal self-injury only versus suicide attempt in a population-based cohort of adults
Article

Spatiotemporal analysis exploring the effect of law enforcement drug market disruptions on overdose, Indianapolis, Indiana, 2020-2021
Article

Protocol for the formative phase of a trial (SHE-CAN) to test co-designed implementation strategies for HPV-based cervical screening among vulnerable women in two diverse settings in India